LEO 19123
Alternative Names: Calcipotriol/LEO 80122; LEO 19123 cream; LEO-19123Latest Information Update: 28 Mar 2011
At a glance
- Originator LEO Pharma
- Class Skin disorder therapies
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Plaque psoriasis
- Discontinued Atopic dermatitis; Eczema
Most Recent Events
- 25 Sep 2005 Preclinical trials in Eczema in Denmark (unspecified route)